United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - liquid paraffin; self-emulsifying glyceryl monostearate; cetomacrogol emulsifying wax; phenoxyethanol; calamine; zinc oxide - cutaneous cream - 200mg/1gram ; 50mg/1gram ; 50mg/1gram ; 5mg/1gram ; 40mg/1gram ; 30mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - liquid paraffin; self-emulsifying glyceryl monostearate; cetomacrogol emulsifying wax; phenoxyethanol; calamine; zinc oxide - cutaneous cream - 200mg/1gram ; 50mg/1gram ; 50mg/1gram ; 5mg/1gram ; 40mg/1gram ; 30mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - calamine; zinc oxide; liquid paraffin; self-emulsifying glyceryl monostearate; cetomacrogol emulsifying wax; phenoxyethanol - cream - 40mg/1gram ; 30mg/1gram ; 200mg/1gram ; 50mg/1gram ; 50mg/1gram ; 5mg/1gram

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 0.021%{relative} (micronized); triamcinolone acetonide 0.021%{relative} (micronized) - topical cream - 0.02% w/w - active: triamcinolone acetonide 0.021%{relative} (micronized) excipient: benzyl alcohol emulsifying wax glycerol isopropyl palmitate lactic acid purified water sorbitol active: triamcinolone acetonide 0.021%{relative} (micronized) excipient: benzyl alcohol emulsifying wax glycerol isopropyl palmitate lactic acid purified water sorbitol - in the treatment of the following dermatoses; atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, eczematised psoriasis, neurodermatitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; benzyl alcohol; lactic acid; purified water; glycerol; sorbitol solution (70 per cent) (non-crystallising); isopropyl palmitate - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - triamcinolone acetonide 0.05%{relative};  ;   - topical cream - 0.05 % - active: triamcinolone acetonide 0.05%{relative}     excipient: benzyl alcohol emulsifying wax glycerol isopropyl palmitate lactic acid purified water sodium hydroxide sorbitol as 70% solution

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - hydrocortisone acetate 10.5%{relative} (includes 5 % excess) - foam - 10% w/w - active: hydrocortisone acetate 10.5%{relative} (includes 5 % excess) excipient: cetyl alcohol emulsifying wax methyl hydroxybenzoate polyoxyethylene stearyl ether propyl hydroxybenzoate propylene glycol purified water trolamine - colifoam rectal foam is indicated for topical treatment of inflammation occurring in the rectal mucosa, e.g. ulcerative colitis, proctosigmoiditis and granular proctitis.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - metronidazole 0.75%{relative} - topical cream - 0.75% w/w - active: metronidazole 0.75%{relative} excipient: benzyl alcohol emulsifying wax glycerol isopropyl palmitate lactic acid purified water sodium hydroxide sorbitol

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - budesonide, quantity: 2 mg - foam - excipient ingredients: propylene glycol; purified water; emulsifying wax; cetyl alcohol; citric acid monohydrate; disodium edetate; butane; isobutane; propane; steareth-10 - budenofalk foam is indicated in the treatment of active rectal and rectosigmoid disease in ulcerative colitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; lactic acid; purified water; isopropyl palmitate; glycerol; benzyl alcohol; sorbitol solution (70 per cent) (non-crystallising) - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.